Tag: Immunochemotherapy for cholangiocarcinoma

Home / Immunochemotherapy for cholangiocarcinoma

Categories

Pembrolizumab with chemotherapy is approved by the USFDA for biliary tract cancer

On October 31, 2023, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) to be used with gemcitabine and cisplatin to treat biliary tract carcinoma (BTC) that has spread or is l...
immunochemotherapy-for-cholangiocarcinoma

We Are Online! Chat With Us!
Scan the code